celecoxib has been researched along with genistein in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Gravitz, L | 1 |
| Lee, YK; Park, OJ | 1 |
| Cai, N; Liu, NN; Zhao, N | 1 |
| Gueler, F; Jang, MS; Meschede, AK; Schebb, NH; Shushakova, N; Willenberg, I | 1 |
| Chen, Y; Guo, F; Li, Y; Tian, J; Yu, B | 1 |
9 other study(ies) available for celecoxib and genistein
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Chemoprevention: First line of defence.
Topics: Animals; Aspirin; Celecoxib; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclooxygenase Inhibitors; Disease Models, Animal; Disease Progression; Female; Focal Adhesion Protein-Tyrosine Kinases; Genistein; Humans; Inflammation; Male; Matrix Metalloproteinase 2; Mice; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Polyamines; Precancerous Conditions; Prostatic Neoplasms; Pyrazoles; Risk Assessment; Sulfonamides | 2011 |
Soybean isoflavone genistein regulates apoptosis through NF-κB dependent and independent pathways.
Topics: Animals; Apoptosis; Blotting, Western; Celecoxib; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Genistein; Glycine max; In Situ Nick-End Labeling; NF-kappa B; Pyrazoles; Reactive Oxygen Species; Sulfonamides | 2013 |
The effect and mechanism of celecoxib in hypoxia-induced survivin up-regulation in HUVECs.
Topics: Celecoxib; Cell Hypoxia; Cell Proliferation; Cobalt; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Gene Expression Regulation; Genistein; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitor of Apoptosis Proteins; Survivin; Up-Regulation | 2015 |
Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Celecoxib; Cell Line, Tumor; Cells, Cultured; Cyclooxygenase 2; Enzyme Activation; Genistein; Humans; Indomethacin; Lipopolysaccharides; Male; Mice, Inbred C57BL; Monocytes; Polyphenols; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes | 2015 |
Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation.
Topics: Anticarcinogenic Agents; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Genistein; Humans; Liposomes; Male; Nanostructures; Prostatic Neoplasms; Signal Transduction | 2019 |